Mazree, a cutting-edge provider of medical equipment disposition services, has announced a strategic partnership with Capstone Health Alliance, one of the largest regional group purchasing organizations in the U.S. healthcare sector.

SALT LAKE CITY, January 9, 2024 (Newswire.com) - Mazree, a cutting-edge provider of medical equipment disposition services, has announced a strategic partnership with Capstone Health Alliance, one of the largest regional group purchasing organizations in the U.S. healthcare sector. The new collaboration combines Mazree's expertise in equipment value recovery with Capstone's vast industry leadership to benefit Capstone members significantly.

Capstone Health Alliance has a proven track record of delivering value and savings to its members through strategic partnerships with leading suppliers. By partnering with Mazree, Capstone aims to enhance its equipment value recovery capabilities and provide innovative solutions to its members. With its advanced medical equipment auction platform, Mazree has transformed the way buyers and sellers of medical equipment connect, enabling healthcare facilities to sell surplus and retired equipment to a vast network of trusted buyers.

The partnership highlights include streamlined asset management, enhanced financial returns, elevated environmental responsibility, and advanced software with transparent reporting. By leveraging Mazree's expert asset disposition services, Capstone Health Alliance members can efficiently manage surplus or retired medical equipment and optimize resource utilization and space management. Through Mazree's targeted approach and extensive network, members can unlock the total value of their surplus equipment, providing an additional revenue stream that can be strategically reinvested in the healthcare ecosystem.

Capstone and Mazree are firmly committed to sustainability and environmental responsibility in healthcare. By choosing Mazree, Capstone members can demonstrate their shared value of prioritizing responsible recycling, resale, and donation practices. Mazree's advanced software offers Capstone members a seamlessly integrated solution, providing real-time updates through user-friendly software, automating workflows, and centralizing asset management. Mazree's analytics capabilities empower data-driven decision-making, ensuring members are audit-ready and facilitating strategic planning. This commitment to transparency and software strengthens Capstone Health Alliance's reputation for excellence in the industry.

"This strategic partnership marks a significant milestone in Mazree's commitment to providing unparalleled value in the healthcare sector. By combining Capstone’s membership network with Mazree's cutting-edge solutions, we are eager to reshape the landscape of equipment value recovery," said Curtis McEntire, President of Mazree.

“Key partnerships are fostered when a need is identified, and solutions are required,” stated Tim Bugg, president, and CEO of Capstone Health Alliance. “This collaboration with Mazree will allow our Members to recoup significant funds and repurpose equipment that would otherwise sit dormant or find its way to a landfill. Need identified. Solution procured and now available for all Capstone Members.”

About Mazree:

Mazree is a leader in medical equipment disposition services, providing an advanced auction platform that maximizes the value of surplus and retired medical equipment for healthcare facilities. With a commitment to innovation and efficiency, Mazree transforms the industry by providing a seamless and value-driven experience. To learn more about Mazree, please visit www.mazree.com

About Capstone Health Alliance:

Headquartered in Asheville, NC, Capstone Health Alliance is a leading regional group purchasing organization (GPO) that collaborates with hundreds of hospitals and thousands of healthcare providers nationwide. Capstone’s primary goal is to deliver tangible savings and provide actionable data to enable informed supply chain decisions. Capstone is committed to helping Members reduce costs, enhance quality, and foster the exchange of best practices. This is achieved through an unwavering dedication to price parity, offering consistent savings regardless of organizational size or location. Capstone Members also gain exclusive access to educational opportunities and benefit from the expertise of their dedicated team of supply chain professionals. To learn more about Capstone Health Alliance and how their innovative solutions can benefit your organization, please visit www.capstonehealthalliance.com

Contact Information:
Erin Peck
Mazree - Director of Marketing and Sales
[email protected]
(630) 362-9381

Tracey Johnston-Crum
Capstone - Sr. Director of Marketing & PR
[email protected]
(828) 216-5813


Original Source: Mazree and Capstone Health Alliance Join Forces to Revolutionize Equipment Value Recovery in Healthcare

A new publication dedicated to making implant dentistry more accessible to all.

NEWPORT BEACH, Calif., January 5, 2024 (Newswire.com) - The new Integrate^™ magazine is now available in print and online at integratemagazine.net. With a focus on restorative-driven implantology, Glidewell created Integrate to give practitioners the knowledge and tools to make implant dentistry an integral part of their practice. Readers can explore topics on innovative technologies and techniques to provide patients with the highest-quality dental care.

“In this inaugural issue of Integrate magazine, clinicians can find clinical instructions for making implants profitable in their practice,” said Dr. Neil Park, vice president of clinical affairs at Glidewell. “From Dr. Charles Schlesinger’s article on bone grafting, to Dr. Randolph Resnik’s discussion of prophylactic antibiotic use, to Dr. Shankar Iyer’s unique case utilizing tilted implants in the partially edentulous maxilla — this issue is something clinicians are going to want to hold on to.”

The cover story features a father and son duo, Drs. Randolph Resnik and Christopher Resnik, who share their passion for implant dentistry and give valuable insights on the future of prosthodontics. Additionally, Dr. Taylor Manalili outlines how the use of digital impressions with implant cases makes it easier for the lab to provide a precise, well-fitting restoration with little discomfort to the patient. Readers will also find Dr. Paresh Patel’s article on implementing the buccal roll technique for the augmentation of keratinized tissue.

Implant dentistry is distinct from other areas of restorative dentistry, which is why Glidewell created Integrate as an addition to its long-running magazine, Chairside ^®. Glidewell is dedicated to making Integrate magazine a go-to resource for practitioners who are looking to improve their implant dentistry skills or add these services to their practice.

Contact Information:
Eldon Thompson
Sr. Director of Marketing
[email protected]


Original Source: Glidewell Publishes Inaugural Edition of Integrate™ Magazine

Rohit Gupta, a Nationally Recognized Scientist, Biobank and Data Expert, is Named as Metrodora Institute's New Chief Scientific Officer and Head of R&D

SALT LAKE CITY, January 5, 2024 (Newswire.com) - Metrodora Institute, a leading multispecialty healthcare institute, announces the hiring of Rohit Gupta, a nationally recognized scientist, biobank, and data expert, as its new Chief Scientific Officer and Head of R&D. This move comes on the heels of other recent leadership announcements, including Dr. Brent Goodman as Metrodora’s Chief Medical Officer. Gupta’s hire solidifies the continuing commitment to Metrodora’s vision of reimagining care across multisystem disorders. By breaking down the silos between clinical care and scientific research, Dr. Goodman and Gupta, as leading pioneers in their respective fields, will collaborate to make this model come to life, ensuring that patient care and access inform and fuel research to direct a more personalized approach.

Gupta will enable Metrodora Institute to drive cutting-edge clinical trials, develop new diagnostic tests, lead collaborations in both academia and industry circles, launch landmark studies and bring new insights and treatments. “Throughout my career, I’ve been fortunate to be a part of and witness the impact of precision medicine in areas like cancer, autoimmune, neurology, and infectious diseases. I’m humbled to be joining Metrodora, as this mission is personal for me. My wife and millions like her have suffered long enough with these chronic, debilitating, and misunderstood conditions, such as CFS/ME, POTS, Long COVID, Ehlers Danlos Syndrome (EDS), ALS, Sjogren’s, and many more,” says Gupta. One of his top priorities this winter is launching a much-needed study to characterize multisystem dysfunction associated with Metrodora Institute's patients. “Often times, patients present with multiple overlapping conditions, and, to date, there is no standardized way to diagnose and treat these patients at the root of the issue. By converging patient care with real-world data and best-in-class genetic and immune technologies, we will start to uncover new biological drivers and advance effective interventions to improve the quality of life for our patients.”

Gupta brings over two decades of life science experience to his new role as Chief Scientific Officer and Head of R&D at Metrodora Institute. He has extensive experience in leading research enterprises and developing innovative medical technology in both academia and industry sectors. He has spearheaded innovation, R&D, and business development efforts for several companies, with a passion to improve access to healthcare for millions through novel laboratory diagnostics and data-driven solutions. Known as one of the world’s foremost biobanking experts, Gupta has also pioneered new methodologies to rethink how scientific discovery using biospecimens and data is used as a vehicle to drive clinical applications. 

“We couldn’t be more thrilled to welcome Rohit Gupta to Metrodora,” said John Wirthlin, CEO, Metrodora Institute. “He brings with him unique expertise across science and business that will accelerate our vision. With his leadership, we can be certain that Metrodora Institute will achieve its goals of developing and adopting new solutions that will improve the lives of the patients we serve.” 

An active leader within the scientific community, Gupta has twice served as the Chairman of the International Society for Biological and Environmental Repositories (ISBER) annual conference, is the Section Editor for "Emerging Markets and Technology" of the peer-reviewed journal "Biobanking and Biopreservation," and won multiple awards for leadership. Among his many professional accomplishments, Gupta also dedicates time to serve in the non-profit space, including advisory board roles that bring medical advancements to underserved populations. 

About Metrodora Institute — Located in Salt Lake City, Utah, the Metrodora Institute was founded in 2021 with the vision of reimagining care for patients with complex multisystem disorders. Metrodora is uniquely positioned to advance the latest clinical care and develop and commercialize new diagnostic tests and therapeutics for patients living with these often-debilitating conditions. Metrodora Institute has created an innovative offering with a collaborative multidisciplinary approach to medicine. Metrodora currently treats neurological, gastrointestinal, immunological, autoimmune, pain and metabolic disorders.

Contact Information:
Kainoa Clark
Chief Marketing Officer
[email protected]
801-473-2119


Original Source: Metrodora Institute Announces New Chief Scientific Officer

NEW YORK, January 5, 2024 (Newswire.com) - Zen Dog Veterinary Care, New York City's premier in-home pet euthanasia service, is thrilled to announce its expansion into Westchester County. At Zen Dog, we are dedicated to providing pets with dignified passing in the comfort of home surrounded by family.

This expansion enables us to offer our unique veterinary services to numerous towns across Westchester, ensuring that more pets can receive a peaceful passing in their home. Zen Dog has been providing home euthanasia services since 2020.

"We are excited to bring our specialized care to Westchester," says Dr. Ray Spragley, CEO at Zen Dog. "Our approach is to treat each pet with dignity, and with our expansion, we can extend this important service to more communities."

Zen Dog Veterinary Care is now offering its unique veterinary services to a wide range of towns in Westchester County. This includes Yonkers, Bronxville, Tuckahoe, Mount Vernon, New Rochelle, Larchmont, Eastchester, the Village of Pelham, Pelham, Mamaroneck, Harrison, Port Chester, Rye, Rye Brook, Purchase, West Harrison, White Plains, Scarsdale, Greenville, Ardsley, Hastings-On-Hudson, Dobbs Ferry, Irvington, Elmsford, Hartsdale, Tarrytown, Valhalla, Sleepy Hollow, Hawthorne, Thornwood, Pleasantville, Briarcliff Manor, Ossining, and Armonk. Each of these communities now has access to this specialized home euthanasia service provided by Zen Dog, bringing a new level of compassionate care to pets in need.

Contact Information:

Email: [email protected]

Phone: (917)-725-2755

Website: https://www.zendogvet.net/

About Zen Dog Veterinary Care:

Zen Dog Veterinary Care provides at home pet euthanasia services in Westchester, Manhattan, Bronx, Brooklyn, and Queens. Coming to the decision to euthanize your pet is among the most difficult choices you will ever have to make. We strive to make this time a little less difficult by ensuring that your final moments together are spent in the comfort of home rather than a veterinary hospital. 

Contact Information:
Raymond Spragley
CEO
[email protected]
917-725-2755


Original Source: Zen Dog Veterinary Care Expands Services to Westchester

EMERYVILLE, Calif., January 5, 2024 (Newswire.com) - Radiance Therapeutics, an innovation leader in ophthalmic devices, is delighted to announce that its CEO, Laurence Marsteller, MSc. MD, will be presenting the company at Biotech Showcase™ 2024 in San Francisco, CA.

This year, registered attendees can view Radiance Therapeutics’ presentation live and also access a recorded version.

Radiance Therapeutics will be presenting on Tuesday, January 9, 2024, at 4:30 p.m. PST at the Hilton San Francisco - Union Square Franciscan A (Ballroom Level).

Dr. Laurence Marsteller will be sharing with the distinguished audience the latest developments from Radiance Therapeutics, focusing on how the company’s innovation can address unmet needs and make significant strides towards improving ophthalmic treatments. 

CEO Laurence Marsteller is available to meet investors in San Francisco. 

“I am excited to represent Radiance Therapeutics at Biotech Showcase,” said Dr. Marsteller. “Recently, Radiance received both US FDA 510(k) regulatory clearance and a U.S. patent. These commercial milestones endow the company with IP-protected and regulator-approved market access to the world’s richest medical device economy. Our commercial innovation aligns seamlessly with this conference's compelling forum for funding transformative healthcare solutions.”

Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year in San Francisco during the course of one of the industry's largest gatherings and busiest weeks.

“We are delighted that Radiance Therapeutics will be joining us in San Francisco and presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime opportunity for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”

Interested parties can register to attend the event here:

https://informaconnect.com/biotech-showcase/registration-options/

END

For additional information about Radiance Therapeutics and its technology, please contact:

Radiance Therapeutics CEO, Laurence Marsteller: [email protected]

Giorgio Pirazzini, GP Communications: [email protected] 

Contact Information:
Laurence Marsteller
Radiance Therapeutics CEO
[email protected]

Giorgio Pirazzini
GP Communications
[email protected]


Original Source: Radiance Therapeutics to Present at the Biotech Showcase 2024 in San Francisco